- Home
- CHRS vs NEOV Comparison
CHRS vs NEOV Comparison
Compare CHRS & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- NEOV
- Stock Information
- Founded
- CHRS 2010
- NEOV 2018
- Country
- CHRS United States
- NEOV United States
- Employees
- CHRS N/A
- NEOV N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- NEOV Industrial Machinery/Components
- Sector
- CHRS Health Care
- NEOV Miscellaneous
- Exchange
- CHRS Nasdaq
- NEOV Nasdaq
- Market Cap
- CHRS 159.2M
- NEOV 153.9M
- IPO Year
- CHRS 2014
- NEOV N/A
- Fundamental
- Price
- CHRS $1.35
- NEOV $4.98
- Analyst Decision
- CHRS Strong Buy
- NEOV Strong Buy
- Analyst Count
- CHRS 4
- NEOV 1
- Target Price
- CHRS $4.51
- NEOV $7.50
- AVG Volume (30 Days)
- CHRS 1.2M
- NEOV 241.2K
- Earning Date
- CHRS 11-05-2025
- NEOV 11-07-2025
- Dividend Yield
- CHRS N/A
- NEOV N/A
- EPS Growth
- CHRS N/A
- NEOV N/A
- EPS
- CHRS 1.55
- NEOV N/A
- Revenue
- CHRS $272,209,000.00
- NEOV $4,255,136.00
- Revenue This Year
- CHRS N/A
- NEOV $208.50
- Revenue Next Year
- CHRS $109.48
- NEOV $128.75
- P/E Ratio
- CHRS $0.87
- NEOV N/A
- Revenue Growth
- CHRS 52.33
- NEOV 52.64
- 52 Week Low
- CHRS $0.66
- NEOV $1.80
- 52 Week High
- CHRS $2.43
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- CHRS 64.99
- NEOV 63.40
- Support Level
- CHRS $1.23
- NEOV $4.85
- Resistance Level
- CHRS $1.40
- NEOV $5.41
- Average True Range (ATR)
- CHRS 0.08
- NEOV 0.34
- MACD
- CHRS -0.00
- NEOV 0.17
- Stochastic Oscillator
- CHRS 72.13
- NEOV 78.62
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.